Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
Karyotype is an independent pr...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
Detalles Bibliográficos
Main Authors:
Moorman, A
,
Harrison, C
,
Buck, G
,
Richards, S
,
Secker-Walker, L
,
Martineau, M
,
Vance, G
,
Cherry, A
,
Higgins, R
,
Fielding, A
,
Foroni, L
,
Paietta, E
,
Tallman, MS
,
Wernik, P
,
Litzow, MR
,
Rowe, J
,
Goldstone, A
,
Dewald, G
Formato:
Conference item
Publicado:
2007
Existencias
Descripción
Títulos similares
Staff View
Títulos similares
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
por: Moorman, A, et al.
Publicado: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
por: Moorman, A, et al.
Publicado: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
por: Moorman, A, et al.
Publicado: (2005)
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
por: Fielding, A, et al.
Publicado: (2010)
Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
por: Fielding, A, et al.
Publicado: (2010)